These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 21349419)
1. Targeted radiotherapy with radiolabeled somatostatin analogs. Nicolas G; Giovacchini G; Müller-Brand J; Forrer F Endocrinol Metab Clin North Am; 2011 Mar; 40(1):187-204, ix-x. PubMed ID: 21349419 [TBL] [Abstract][Full Text] [Related]
2. Somatostatin receptor-targeted radionuclide therapy in patients with gastroenteropancreatic neuroendocrine tumors. Kwekkeboom DJ; de Herder WW; Krenning EP Endocrinol Metab Clin North Am; 2011 Mar; 40(1):173-85, ix. PubMed ID: 21349418 [TBL] [Abstract][Full Text] [Related]
3. Radiolabeled somatostatin analogs for radionuclide imaging and therapy in patients with gastroenteropancreatic neuroendocrine tumors. Bal CS; Gupta SK; Zaknun JJ Trop Gastroenterol; 2010; 31(2):87-95. PubMed ID: 20862981 [TBL] [Abstract][Full Text] [Related]
4. Radiolabeled somatostaitin analogs in the treatment of neuroendocrine tumors: experience of the National Cancer Institute of Milano using high dose of 111In-pentetreotide in metastatic neuroendocrine gastroenteropancreatic tumors. Bombardieri E; Seregni E; Savelli G; Villano C; Castellani MR; Cirillo F; Pallotti F; Fracassi S; Chiesa C; Chiti A; Bajetta E J Endocrinol Invest; 2003; 26(8 Suppl):63-9. PubMed ID: 15233216 [No Abstract] [Full Text] [Related]
5. Nuclear medicine techniques for the imaging and treatment of neuroendocrine tumours. Teunissen JJ; Kwekkeboom DJ; Valkema R; Krenning EP Endocr Relat Cancer; 2011 Oct; 18 Suppl 1():S27-51. PubMed ID: 22005114 [TBL] [Abstract][Full Text] [Related]
6. Peptide receptor radionuclide therapy (PRRT) of neuroendocrine tumors with somatostatin analogues. Bodei L; Pepe G; Paganelli G Eur Rev Med Pharmacol Sci; 2010 Apr; 14(4):347-51. PubMed ID: 20496546 [TBL] [Abstract][Full Text] [Related]
7. Somatostatin-receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors. Kwekkeboom DJ; Kam BL; van Essen M; Teunissen JJ; van Eijck CH; Valkema R; de Jong M; de Herder WW; Krenning EP Endocr Relat Cancer; 2010 Mar; 17(1):R53-73. PubMed ID: 19995807 [TBL] [Abstract][Full Text] [Related]
8. Molecular radiotherapy with somatostatin analogs for (neuro-)endocrine tumors. Krenning EP; Teunissen JJ; Valkema R; deHerder WW; deJong M; Kwekkeboom DJ J Endocrinol Invest; 2005; 28(11 Suppl International):146-50. PubMed ID: 16625865 [TBL] [Abstract][Full Text] [Related]
9. Somatostatin receptor-mediated imaging and therapy: basic science, current knowledge, limitations and future perspectives. Breeman WA; de Jong M; Kwekkeboom DJ; Valkema R; Bakker WH; Kooij PP; Visser TJ; Krenning EP Eur J Nucl Med; 2001 Sep; 28(9):1421-9. PubMed ID: 11585303 [TBL] [Abstract][Full Text] [Related]
10. Molecular imaging as in vivo molecular pathology for gastroenteropancreatic neuroendocrine tumors: implications for follow-up after therapy. Krenning EP; Valkema R; Kwekkeboom DJ; de Herder WW; van Eijck CH; de Jong M; Pauwels S; Reubi JC J Nucl Med; 2005 Jan; 46 Suppl 1():76S-82S. PubMed ID: 15653655 [TBL] [Abstract][Full Text] [Related]
11. [Somatostatin receptor endoradiotherapy of neuroendocrine tumors: experience in Hungarian patients]. Reismann P; Kender Z; Dabasi G; Sréter L; Rácz K; Igaz P Orv Hetil; 2011 Mar; 152(10):392-7. PubMed ID: 21354955 [TBL] [Abstract][Full Text] [Related]
12. Therapy with radiolabeled somatostatin peptide analogs for metastatic neuroendocrine tumors. Bushnell D J Gastrointest Surg; 2006 Mar; 10(3):335-6. PubMed ID: 16622984 [No Abstract] [Full Text] [Related]
13. Somatostatin receptor imaging with indium-111-pentetreotide in gastroenteropancreatic neuroendocrine tumors: safety, efficacy and impact on patient management. Jamar F; Fiasse R; Leners N; Pauwels S J Nucl Med; 1995 Apr; 36(4):542-9. PubMed ID: 7699439 [TBL] [Abstract][Full Text] [Related]
14. Tumor imaging and therapy using radiolabeled somatostatin analogues. de Jong M; Breeman WA; Kwekkeboom DJ; Valkema R; Krenning EP Acc Chem Res; 2009 Jul; 42(7):873-80. PubMed ID: 19445476 [TBL] [Abstract][Full Text] [Related]
15. Beta-emitting radionuclides for peptide receptor radionuclide therapy. Parus JL; Mikolajczak R Curr Top Med Chem; 2012; 12(23):2686-93. PubMed ID: 23339764 [TBL] [Abstract][Full Text] [Related]
16. Treatment with (90)Y- and (177)Lu-DOTATOC in patients with metastatic neuroendocrine tumors. Frilling A; Weber F; Saner F; Bockisch A; Hofmann M; Mueller-Brand J; Broelsch CE Surgery; 2006 Dec; 140(6):968-76; discussion 976-7. PubMed ID: 17188146 [TBL] [Abstract][Full Text] [Related]
17. In situ radiotherapy with 111In-pentetreotide: initial observations and future directions. McCarthy KE; Woltering EA; Espenan GD; Cronin M; Maloney TJ; Anthony LB Cancer J Sci Am; 1998; 4(2):94-102. PubMed ID: 9532411 [TBL] [Abstract][Full Text] [Related]
18. Peptide receptor imaging and therapy. Kwekkeboom D; Krenning EP; de Jong M J Nucl Med; 2000 Oct; 41(10):1704-13. PubMed ID: 11038002 [TBL] [Abstract][Full Text] [Related]